Laurion Capital Management’s Impax Laboratories, Inc. IPXL Stock Holding History

Laurion Capital Management’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-14,500	Closed	-$183K	–	2036
2017 Q1	$183K	Buy	+14,500	New	+$175K	﹤0.01%	1209
2015 Q4	–	Sell	-7,800	Closed	-$275K	–	1160
2015 Q3	$275K	Buy	+7,800	New	+$351K	﹤0.01%	614

Other funds holding IPXL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Laurion Capital Management's IPXL Position: Q2 2017 in Review

Laurion Capital Management sold out of Impax Laboratories, Inc. (IPXL) in Q2 2017, closing a stake of 14,500 shares — an estimated $183K sold.

Laurion Capital Management first reported a position in IPXL in Q3 2015 and held it in 2 quarters. The position peaked at $275K in Q3 2015. 172 funds tracked by Wall St. Rank hold IPXL as of Q2 2017.

Laurion Capital Management reported no remaining Impax Laboratories, Inc. position as of Q2 2017 after selling out during the quarter.
Laurion Capital Management sold 14,500 Impax Laboratories, Inc. shares in Q2 2017, an estimated $183K.
Laurion Capital Management first reported a position in Impax Laboratories, Inc. in Q3 2015 and held it in 2 quarters.
Laurion Capital Management's Impax Laboratories, Inc. position peaked at $275K in Q3 2015.
172 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2017.

Based on Laurion Capital Management's 13F filing for Q2 2017, filed 11 Aug 2017.